Get started
Author

Daniel Hantaı̈

Observed names: D HANTAI, D Hantai, D Hantaï, D Hantaı̈, D. Hantai, D. Hantaï, D. Hantaï, Daniel Hanta Ï, Daniel Hantai, Daniel Hantaï, Daniel Hantaï, Daniel Hantaï, Daniel, Hantaï, HANTAÏ, Daniel, Hantai, D., Hantai, Daniel, Hantaï, D., Hantaï, Daniel
Observed institutions: Centre National de la Recherche Scientifique, Inserm, Université Paris-Est Créteil, Veterans Health Administration, Sorbonne Université, Institut des Sciences Moléculaires, Assistance Publique – Hôpitaux de Paris, Institut de Myologie, Pitié-Salpêtrière Hospital, University of Kansas Medical Center, Institut du Cerveau, Kansas City VA Medical Center, Université Pierre-et-Marie-Curie, Cœur, Muscle et Vaisseaux
OpenAlex ID: A5077640627
Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy
2009 · Valérie Risson, Laetitia Mazelin, et al. · The Journal of Cell Biology · 381
PDF
Constitutive Activation of the Calcium Sensor STIM1 Causes Tubular-Aggregate Myopathy
2013 · Johann Böhm, Frédéric Chevessier, et al. · The American Journal of Human Genetics · 219
PDF
MUSK, a new target for mutations causing congenital myasthenic syndrome
2004 · Frédéric Chevessier, Brice Faraut, et al. · Human Molecular Genetics · 193
Identification of an Agrin Mutation that Causes Congenital Myasthenia and Affects Synapse Function
2009 · Caroline Huzé, Stéphanie Bauché, et al. · The American Journal of Human Genetics · 172
PDF
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression
2013 · Gaëlle Bruneteau, Thomas Simonet, et al. · Brain · 137
Congenital myasthenic syndromes
2013 · Bruno Eymard, Daniel Hantaï, et al. · Handbook of clinical neurology · 129
Lamin A/C–mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy
2009 · Alexandre Méjat, Valérie Decostre, et al. · The Journal of Cell Biology · 121
PDF
Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy
2014 · Sophie Nicole, Amina Chaouch, et al. · Brain · 105
Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients
2015 · Gaëlle Bruneteau, Stéphanie Bauché, et al. · Annals of Clinical and Translational Neurology · 97
PDF
The origin of tubular aggregates in human myopathies
2005 · Frédéric Chevessier, Stéphanie Bauché‐Godard, et al. · The Journal of Pathology · 96
Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease
1995 · D. Hantaï, M. Akaaboune, et al. · Journal of the Neurological Sciences · 92
126th International Workshop: Congenital Myasthenic Syndromes, 24–26 September 2004, Naarden, The Netherlands
2005 · David Beeson, Daniel Hantaï, et al. · Neuromuscular Disorders · 89
Tubular aggregates are from whole sarcoplasmic reticulum origin: alterations in calcium binding protein expression in mouse skeletal muscle during aging
2004 · F Chevessier, I Marty, et al. · Neuromuscular Disorders · 86
Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7
2009 · A. Ben Ammar, F. Petit, et al. · Journal of Neurology · 81
Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations
2011 · I. Wargon, P. Richard, et al. · Neuromuscular Disorders · 78
PDF
Congenital myasthenic syndromes
2004 · Daniel Hantaï, Pascale Richard, et al. · Current Opinion in Neurology · 75
A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromuscular junctions
2008 · F. Chevessier, E. Girard, et al. · Human Molecular Genetics · 68
Plasminogen activators and inhibitors in the neuromuscular system: III. The serpin protease nexin I is synthesized by muscle and localized at neuromuscular synapses
1991 · B. W. Festoff, J. S. Rao, et al. · Journal of Cellular Physiology · 65
Serine Proteases and Their Serpin Inhibitors in the Nervous System
1990 · Barry W. Festoff, Daniel Hantaï · Springer eBooks · 59
Developmental Regulation of Amyloid Precursor Protein at the Neuromuscular Junction in Mouse Skeletal Muscle
2000 · Mohammed Akaaboune, Bernadette Allinquant, et al. · Molecular and Cellular Neuroscience · 58
Decrease in plasminogen activator correlates with synapse elimination during neonatal development of mouse skeletal muscle.
1989 · D Hantaï, J S Rao, et al. · Proceedings of the National Academy of Sciences · 57
Possible founder effect of rapsyn N88K mutation and identification of novel rapsyn mutations in congenital myasthenic syndromes
2003 · P Richard, K Gaudon, et al. · Journal of Medical Genetics · 53
PDF
186th ENMC International Workshop: Congenital myasthenic syndromes 24–26 June 2011, Naarden, The Netherlands
2012 · Amina Chaouch, David Beeson, et al. · Neuromuscular Disorders · 52
A Mutation Causes MuSK Reduced Sensitivity to Agrin and Congenital Myasthenia
2013 · Asma Ben Ammar, Payam Soltanzadeh, et al. · PLoS ONE · 51
PDF
Mutations in GFPT1-related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregate myopathy with synaptopathy
2017 · Stéphanie Bauché, Geoffroy Vellieux, et al. · Journal of Neurology · 48
Works count: 128
Citation count: 3,837
H-index: 34
I10-index: 69
Year
Topic
Type